Latest / Research To Practice | Oncology Videos
HER2-Altered Non-Small Cell Lung Cancer — An Interview with Dr John V Heymach
Featuring an interview with Dr John V Heymach, including the following topics:
Differentiating factors among various HER2 alterations in non-small cell lung cancer (NSCLC) (0:00)
Activity of targeted agents across HER2 alterations in NSCLC (4:06)
Available data with zongertinib and sevabertinib for HER2-mutant NSCLC (20:39)
Case: A man in his late 40s with HER2-mutant NSCLC receives multiple lines of therapy, including trastuzumab deruxtecan (T-DXd) and zongertinib (29:23)
Case: A woman in her mid 50s with HER2-mutant NSCLC receives zongertinib with durable response (34:23)
Case: A woman in…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.